Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rhonda L Bitting

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Prostate Cancer and Prostatic Diseases|April 2, 2024
Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancerDaniel J George, Neeraj Agarwal, Krishnan Ramaswamy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2025
Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO GuidelineEvan Y Yu, R Bryan Rumble, Neeraj Agarwal, et al.
European Journal of Cancer (Oxford, England : 1990)|May 16, 2017
Phase II trial of the PI3 kinase inhibitor buparlisib (BKM-120) with or without enzalutamide in men with metastatic castration resistant prostate cancerAndrew J Armstrong, Susan Halabi, Patrick Healy, et al.
Molecular Carcinogenesis|November 2, 2019
Syntaxin 6-mediated exosome secretion regulates enzalutamide resistance in prostate cancerTaylor C Peak, Gati K Panigrahi, Prakash P Praharaj, et al.
Prostate Cancer and Prostatic Diseases|January 26, 2021
Body composition, physical function and quality of life in healthy men and across different stages of prostate cancerErik D Hanson, Cameron K Stopforth, Mohamdod Alzer, et al.
Prostate Cancer and Prostatic Diseases|March 20, 2022
Feasibility of home-based exercise training in men with metastatic castration-resistant prostate cancerErik D Hanson, Mohamdod Alzer, Jackson Carver, et al.
American Journal of Clinical Oncology|April 19, 2021
Phase I Study of Muscadine Grape Extract for Patients With Advanced CancerRhonda L Bitting, Janet A Tooze, Scott Isom, et al.
European Urology Oncology|February 18, 2020
Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM TrialRhonda L Bitting, Patrick Healy, Daniel J George, et al.
Prostate Cancer and Prostatic Diseases|January 10, 2024
Genomic classifiers and prognosis of localized prostate cancer: a systematic reviewMatthew J Boyer, David J Carpenter, Jeffrey R Gingrich, et al.
Annals of Internal Medicine|January 20, 2025
Impact of Genomic Classifiers on Risk Stratification and Treatment Intensity in Patients With Localized Prostate Cancer : A Systematic ReviewAmir Alishahi Tabriz, Matthew J Boyer, Adelaide M Gordon, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Prostate Cancer and Prostatic Diseases|April 2, 2024
Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancerDaniel J George, Neeraj Agarwal, Krishnan Ramaswamy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2025
Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO GuidelineEvan Y Yu, R Bryan Rumble, Neeraj Agarwal, et al.
European Journal of Cancer (Oxford, England : 1990)|May 16, 2017
Phase II trial of the PI3 kinase inhibitor buparlisib (BKM-120) with or without enzalutamide in men with metastatic castration resistant prostate cancerAndrew J Armstrong, Susan Halabi, Patrick Healy, et al.
Molecular Carcinogenesis|November 2, 2019
Syntaxin 6-mediated exosome secretion regulates enzalutamide resistance in prostate cancerTaylor C Peak, Gati K Panigrahi, Prakash P Praharaj, et al.
Prostate Cancer and Prostatic Diseases|January 26, 2021
Body composition, physical function and quality of life in healthy men and across different stages of prostate cancerErik D Hanson, Cameron K Stopforth, Mohamdod Alzer, et al.
Prostate Cancer and Prostatic Diseases|March 20, 2022
Feasibility of home-based exercise training in men with metastatic castration-resistant prostate cancerErik D Hanson, Mohamdod Alzer, Jackson Carver, et al.
American Journal of Clinical Oncology|April 19, 2021
Phase I Study of Muscadine Grape Extract for Patients With Advanced CancerRhonda L Bitting, Janet A Tooze, Scott Isom, et al.
European Urology Oncology|February 18, 2020
Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM TrialRhonda L Bitting, Patrick Healy, Daniel J George, et al.
Prostate Cancer and Prostatic Diseases|January 10, 2024
Genomic classifiers and prognosis of localized prostate cancer: a systematic reviewMatthew J Boyer, David J Carpenter, Jeffrey R Gingrich, et al.
Annals of Internal Medicine|January 20, 2025
Impact of Genomic Classifiers on Risk Stratification and Treatment Intensity in Patients With Localized Prostate Cancer : A Systematic ReviewAmir Alishahi Tabriz, Matthew J Boyer, Adelaide M Gordon, et al.
Pageof 5